FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!

Anika Therapeutics Inc. Stock Forecast NASDAQ:ANIK

Price Target and Analyst Ratings

Most Recent Rating

On July 16, 2021 "UBS Group" gave "" rating for ANIK. The price target was changed from $40.78 to 1.4%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-16 Initiated by UBS Group $40.68 $40.78→1.4%
2020-12-16 Market Perform - Outperform Upgraded by Barrington Research $40.95 $43.00
2020-05-08 Outperform - Market Perform Downgraded by Barrington Research $30.54

ANIK Stock Trend

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $39.03 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -4.19% during the next 3 months and, with a 90% probability hold a price between $37.40 and $44.74 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-08-03 $39.00 $42.83 $46.66
2021-08-04 $38.97 $42.80 $46.63
2021-08-05 $38.94 $42.77 $46.60
2021-08-06 $38.90 $42.73 $46.56
2021-08-09 $38.87 $42.70 $46.53
2021-08-10 $38.84 $42.67 $46.50
2021-08-11 $38.80 $42.63 $46.47
2021-08-12 $38.77 $42.60 $46.43
2021-08-13 $38.74 $42.57 $46.40
2021-08-16 $38.70 $42.54 $46.37
2021-08-17 $38.67 $42.50 $46.33
2021-08-18 $38.64 $42.47 $46.30
2021-08-19 $38.61 $42.44 $46.27
2021-08-20 $38.57 $42.40 $46.23
2021-08-23 $38.54 $42.37 $46.20
2021-08-24 $38.51 $42.34 $46.17
2021-08-25 $38.47 $42.31 $46.14
2021-08-26 $38.44 $42.27 $46.10
2021-08-27 $38.41 $42.24 $46.07
2021-08-30 $38.38 $42.21 $46.04
2021-08-31 $38.34 $42.17 $46.00
2021-09-01 $38.31 $42.14 $45.97
2021-09-02 $38.28 $42.11 $45.94
2021-09-03 $38.24 $42.07 $45.91
2021-09-07 $38.21 $42.04 $45.87
2021-09-08 $38.18 $42.01 $45.84
2021-09-09 $38.14 $41.98 $45.81
2021-09-10 $38.11 $41.94 $45.77
2021-09-13 $38.08 $41.91 $45.74
2021-09-14 $38.05 $41.88 $45.71

About Anika Therapeutics Inc.

Anika Therapeutics Anika Therapeutics, Inc., together with its subsidiaries, provides therapeutic pain management solutions for patients with degenerative orthopedic diseases and traumatic conditions in the United States, Canada, Europe, and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, an... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT